Scanadu
closedDate | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$4.2m | Seed | ||
N/A | N/A | Seed | |
$10.5m | Series A | ||
$35.0m | Series B | ||
N/A | $6.5m | Series B | |
Total Funding | CAD76.6m |
Related Content
Recent News about Scanadu
EditScanadu is a pioneering company in the health diagnostics sector, focusing on developing advanced medical devices that enable individuals to monitor their vital signs in real-time. The company primarily serves health-conscious consumers, medical professionals, and researchers who are interested in leveraging technology for better health outcomes. Operating in the digital health market, Scanadu's business model revolves around the sale of its diagnostic devices and related software services. Revenue is generated through direct sales, subscriptions for advanced features, and partnerships with healthcare providers. The company's flagship product, the Scanadu Scout, is a handheld device that measures vital signs such as heart rate, temperature, and blood pressure, providing users with immediate health insights. By empowering users to take control of their health data, Scanadu aims to foster a more proactive approach to healthcare. The company also engages in clinical research to validate the efficacy of its products and expand their applications.
Keywords: health diagnostics, vital signs, real-time monitoring, medical devices, digital health, Scanadu Scout, healthcare technology, patient empowerment, clinical research, health data.